AnGes Inc banner

Intrinsic Value

The intrinsic value of AnGes Inc (AMGXF) under the Base Case is USD per share. Compared with the current market price of 0.3602 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

AMGXF Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when AMGXF is below its intrinsic value
Today Hidden ·
AMGXF Valuation History

Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.

Create a free account · No card needed

Alternatives to AMGXF

Fundamental Analysis

What AnGes Does

Biotechnology Health Care

AnGes Inc. is a Japanese biopharmaceutical company that develops gene-based medicines, with a focus on treatments that use DNA to help the body make therapeutic proteins. Its best-known work has been in areas such as vascular disease, where it has researched gene therapies aimed at improving blood flow, and in vaccines and other DNA-based drug programs. The company does not sell a broad line of consumer products; it is mainly a drug developer that takes scientific ideas through research, testing, and regulatory steps.

Headquarters
Japan JP
Employees
56
IPO date
Sep 25, 2002
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
AnGes Inc

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue AMGXF Research

Decided on AnGes? Get an email when AMGXF reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one AMGXF stock?

The intrinsic value for AnGes Inc (AMGXF) under the Base Case is USD.

Is AMGXF stock undervalued or overvalued?

Compared with the current market price of 0.3602 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top